Branzo Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.20 M
as on 15-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Branzo Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Brijesh Kumar and Sunita Devi serve as directors at the Company.
- CIN/LLPIN
U24290UP2021PTC150743
- Company No.
150743
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2021
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Branzo Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brijesh Kumar  | Director | 16-Aug-2021 | Current |
| Sunita Devi | Director | 16-Aug-2021 | Current |
Financial Performance of Branzo Pharma.
Enhance accessibility to Branzo Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Branzo Pharma?
Unlock access to Branzo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Branzo International Private LimitedActive 5 years 6 monthsBrijesh Kumar and Sunita Devi are mutual person
- Branzo Foods & Beverages Private LimitedActive 3 years 4 months
Brijesh Kumar and Sunita Devi are mutual person
- Branzo Petro Chemicals Private LimitedActive 3 years 4 months
Brijesh Kumar and Sunita Devi are mutual person
- Branzo Aluminium Industries Private LimitedActive 3 years 3 months
Brijesh Kumar and Sunita Devi are mutual person
- Branzo Motors Private LimitedActive 3 years 10 months
Brijesh Kumar and Sunita Devi are mutual person
- Branzo Projects Private LimitedActive 11 years 4 months
Brijesh Kumar and Sunita Devi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Branzo Pharma?
Unlock and access historical data on people associated with Branzo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Branzo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Branzo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
